Glutathione References

Neeley MD, Zimmerman L, et al, " Congeners on N-Acetyl-Cysteine but notaminoguanidine act as
neurprotectants from
the lipid peroxidation product 4-hydroxy-2-nonenal." Free Radical. Biol Med., 2000.

Cynober, L, editor, Amino Acid Metabolism & Therapy in Health & Nutritional Diseases,1995.
Balch, J., MD, Balch, P. Prescription for Nutritional Healing, 1997. - - o Packer L, Ph.D.,Colman, C., The
Antioxidant
Miracle, 2000.

.Olivieri, Baysang et al, "N-Acetyl-L-Cysteine Protects SHSY5Y Neuroblastoma cells fromOxidative Stress
and Cell
Cytotoxicity: Effect on SS-Amyloid Secretion and Ta. Phosphorylation", J. Neurochem., Jan. 2001.

Gaby, M.D., Austin, Batz, Yarnell, Brown, Constantine (Lininger, S. W. editor in chief) A-Z Guide to
Drug-Herb-Vitamin
Interactions, 1999.

Breitkreutz R., Pittack N, et al, "Improvement on Immune Functions in HIV Infection by Sulfur
Supplementation: Two
Randomized Trials," J. Mol. Med., 2000.

Akiu S, Suzuki Y, Asahara T: [Inhibitory effect of arbutin on melanogenesis--biochemical study using
cultured B16
melanoma cells]. Nippon Hifuka Gakkai Zasshi 1991 May; 101(6): 609-13[Medline].

Bessou S, Pain C, Taieb A: Use of human skin reconstructs in the study of pigment modifiers. Arch
Dermatol 1997 Mar;
133(3): 331-6[Medline].

Budavari S, ed: Gentisic acid. In: Merck Index. 11th ed. Rahway, NY: Merck and Co; 1989: 688.

Carsberg CJ, Warenius HM, Friedmann PS: Ultraviolet radiation-induced melanogenesis in human
melanocytes. Effects
of modulating protein kinase C. J Cell Sci 1994 Sep; 107 (Pt 9): 2591-7[Medline].

Chakraborty AK, Funasaka Y, Komoto M: Effect of arbutin on melanogenic proteins in human melanocytes.
Pigment
Cell Res 1998 Aug; 11(4): 206-12[Medline].

Dong-II Jang et al: Melanogenesis inhibitor from paper mulberry. Cosmetics & Toiletries 1997; 112: 59-62.

Dooley TP, Gadwood RC, Kilgore K: Development of an in vitro primary screen for skin depigmentation and
antimelanoma agents. Skin Pharmacol 1994; 7(4): 188-200[Medline].

Glatt H: Endogenous mutagens derived from amino acids. Mutat Res 1990 May; 238(3): 235-43[Medline].

Jimbow K, Iwashina T, Alena F: Exploitation of pigment biosynthesis pathway as a selective
chemotherapeutic
approach for malignant melanoma. J Invest Dermatol 1993 Feb; 100(2 Suppl): 231S-238S[Medline].

Jimbow K: N-acetyl-4-S-cysteaminylphenol as a new type of depigmenting agent for the melanoderma of
patients with
melasma. Arch Dermatol 1991 Oct; 127(10): 1528-34[Medline].

Kameyama K, Sakai C, Kondoh S: Inhibitory effect of magnesium L-ascorbyl-2-phosphate (VC-PMG) on
melanogenesis
in vitro and in vivo. J Am Acad Dermatol 1996 Jan; 34(1): 29-33[Medline].

Katori N, Aoyagi N, Kojima S: [Exceptional Application of Content Uniformity Test and Weight Variation Test
in the
Japanese Pharmacopoeia 13 revision and usage of these tests for in-process tests]. Kokuritsu Iyakuhin
Shokuhin Eisei
Kenkyusho Hokoku 1997; (115): 204-5[Medline].

Kobayashi S, Takehana M, Itoh S: Protective effect of magnesium-L-ascorbyl-2 phosphate against skin
damage
induced by UVB irradiation. Photochem Photobiol 1996 Jul; 64(1): 224-8[Medline].

Nakagawa M, Kawai K, Kawai K: Contact allergy to kojic acid in skin care products. Contact Dermatitis 1995
Jan; 32(1):
9-13[Medline].

Niwa Y, Akamatsu H: Kojic acid scavenges free radicals while potentiating leukocyte functions including
free radical
generation. Inflammation 1991 Aug; 15(4): 303-15[Medline].

Nordland J, ed.: The pigmentary system In: Physiology and Pathophysiology. New York, NY: Oxford
University Press;
1998.

Penney KB, Smith CJ, Allen JC: Depigmenting action of hydroquinone depends on disruption of
fundamental cell
processes. J Invest Dermatol 1984; 82(4): 308-310[Medline].

Schallreuter KU, Wood JW: A possible mechanism of action for azelaic acid in the human epidermis. Arch
Dermatol
Res 1990; 282(3): 168-71[Medline].

Yokota T, Nishio H, Kubota Y: The inhibitory effect of glabridin from licorice extracts on melanogenesis and
inflammation. Pigment Cell Res 1998 Dec; 11(6): 355-61[Medline].